| T-BSDB-H213 |
Recombinant Human Anti-CD16 x Anti-HER2 Bispecific Antibody (Tandem Diabody) |
Human |
|
CD16 |
HER2 |
Inquiry |
| T-BSDB-038 |
Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (Tandem Diabody) |
Human |
|
CD16 |
HER2 |
Inquiry |
| SCIGG-H215 |
Recombinant Human Anti-CD16 x Human Anti-HER2 Bispecific Antibody (scIgG) |
Human |
Single chain IgGs |
CD16 |
HER2 |
Inquiry |
| FABVC-362 |
Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (Fab-VHH-Fc) |
Human |
Fab-Fc Fusion Proteins |
CD16 |
HER2 |
Inquiry |
| BSSG-362 |
Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (VHH-IgG) |
Human |
Appended IgGs |
CD16 |
HER2 |
Inquiry |
| HCAB-007 |
Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (VHH-Fc-VHH) |
Human |
Constant Domain-extended Bispecific Fragments |
CD16 |
HER2 |
Inquiry |
| BIBD-362 |
Recombinant Anti-CD16 x Anti-HER2 VHH BispecificAntibody (Bibody) |
Human |
Bibody |
CD16 |
HER2 |
Inquiry |
| IGVHH-007 |
Recombinant Anti-CD16 x Anti-HER2 VHH BispecificAntibody (IgG-VHH) |
Human |
Appended IgGs |
CD16 |
HER2 |
Inquiry |
| BIVHH-006 |
Recombinant Anti-CD16 VHH x Anti-HER2 VHH BispecificAntibody (Bi-sdAb) |
Human |
Bi-sdAb |
CD16 |
HER2 |
Inquiry |
| SCIGG-038 |
Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (scIgG) |
Human |
Single chain IgGs |
CD16 |
HER2 |
Inquiry |
| FVTIG-H215 |
Recombinant Human Anti-CD16 x Human Anti-HER2 Bispecific Antibody (scFv4-Ig) |
Human |
Appended IgGs |
CD16 |
HER2 |
Inquiry |
| FVTIG-038 |
Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (scFv4-Ig) |
Human |
Appended IgGs |
CD16 |
HER2 |
Inquiry |
| BSSG-H215 |
Recombinant Human Anti-CD16 x Human Anti-HER2 Bispecific Antibody (scFv-IgG) |
Human |
Appended IgGs |
CD16 |
HER2 |
Inquiry |
| BSSG-038 |
Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (scFv-IgG) |
Human |
Appended IgGs |
CD16 |
HER2 |
Inquiry |
| IGLFV-H215 |
Recombinant Human Anti-CD16 x Human Anti-HER2 Bispecific Antibody (IgG(L)-scFv) |
Human |
Appended IgGs |
CD16 |
HER2 |
Inquiry |
| IGLFV-038 |
Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (IgG(L)-scFv) |
Human |
Appended IgGs |
CD16 |
HER2 |
Inquiry |
| BSGV-H215 |
Recombinant Human Anti-CD16 x Human Anti-HER2 Bispecific Antibody (IgG-Fv) |
Human |
IgG-Fv |
CD16 |
HER2 |
Inquiry |
| BSGV-038 |
Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (IgG-Fv) |
Human |
IgG-Fv |
CD16 |
HER2 |
Inquiry |
| BSDG-H215 |
Recombinant Human Anti-CD16 x Human Anti-HER2 Bispecific Antibody (Fv-IgG) |
Human |
Appended IgGs |
CD16 |
HER2 |
Inquiry |
| BSDG-038 |
Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (Fv-IgG) |
Human |
Appended IgGs |
CD16 |
HER2 |
Inquiry |
| BABFV-H215 |
Recombinant Human Anti-CD16 x Human Anti-HER2 Bispecific Antibody (F(ab')2-scFv2) |
Human |
Fab-Fc Fusion Proteins |
CD16 |
HER2 |
Inquiry |
| BABFV-038 |
Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (F(ab')2-scFv2) |
Human |
Fab-Fc Fusion Proteins |
CD16 |
HER2 |
Inquiry |
| FABVC-H215 |
Recombinant Human Anti-CD16 x Human Anti-HER2 Bispecific Antibody (Fab-scFv-Fc) |
Human |
Fab-Fc Fusion Proteins |
CD16 |
HER2 |
Inquiry |
| FABVC-038 |
Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (Fab-scFv-Fc) |
Human |
Fab-Fc Fusion Proteins |
CD16 |
HER2 |
Inquiry |
| SCDBC-H215 |
Recombinant Human Anti-CD16 x Human Anti-HER2 Bispecific Antibody (scDiabody-CH3) |
Human |
Constant Domain-extended Bispecific Fragments |
CD16 |
HER2 |
Inquiry |
| SCDBC-038 |
Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (scDiabody-CH3) |
Human |
Constant Domain-extended Bispecific Fragments |
CD16 |
HER2 |
Inquiry |
| BSDBC-H215 |
Recombinant Human Anti-CD16 x Human Anti-HER2 Bispecific Antibody (Diabody-CH3) |
Human |
Constant Domain-extended Bispecific Fragments |
CD16 |
HER2 |
Inquiry |
| BSDBC-038 |
Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (Diabody-CH3) |
Human |
Constant Domain-extended Bispecific Fragments |
CD16 |
HER2 |
Inquiry |
| SCDBF-H215 |
Recombinant Human Anti-CD16 x Human Anti-HER2 Bispecific Antibody (scDiabody-Fc) |
Human |
Constant Domain-extended Bispecific Fragments |
CD16 |
HER2 |
Inquiry |
| SCDBF-038 |
Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (scDiabody-Fc) |
Human |
Constant Domain-extended Bispecific Fragments |
CD16 |
HER2 |
Inquiry |
| BSFVF-H215 |
Recombinant Human Anti-CD16 x Human Anti-HER2 Bispecific Antibody (Tandem scFv-Fc) |
Human |
Constant Domain-extended Bispecific Fragments |
CD16 |
HER2 |
Inquiry |
| BSFVF-038 |
Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (Tandem scFv-Fc) |
Human |
Constant Domain-extended Bispecific Fragments |
CD16 |
HER2 |
Inquiry |
| BSDBF-H215 |
Recombinant Human Anti-CD16 x Human Anti-HER2 Bispecific Antibody (Diabody-Fc) |
Human |
Constant Domain-extended Bispecific Fragments |
CD16 |
HER2 |
Inquiry |
| BSDBF-038 |
Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (Diabody-Fc) |
Human |
Constant Domain-extended Bispecific Fragments |
CD16 |
HER2 |
Inquiry |
| BSTF-H215 |
Recombinant Human Anti-CD16 x Human Anti-HER2 Bispecific Antibody (scFv-Fc-scFv) |
Human |
scFv-based Bispecific Fragments |
CD16 |
HER2 |
Inquiry |
| BSTF-038 |
Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (scFv-Fc-scFv) |
Human |
scFv-based Bispecific Fragments |
CD16 |
HER2 |
Inquiry |
| BSCFV-H215 |
Recombinant Human Anti-CD16 x Human Anti-HER2 Bispecific Antibody (scFv-Fc) |
Human |
scFv-based Bispecific Fragments |
CD16 |
HER2 |
Inquiry |
| BSCFV-038 |
Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (scFv-Fc) |
Human |
scFv-based Bispecific Fragments |
CD16 |
HER2 |
Inquiry |
| MNAB-H215 |
Recombinant Human Anti-CD16 x Human Anti-HER2 Bispecific Antibody (Miniantibody) |
Human |
scFv-based Bispecific Fragments |
CD16 |
HER2 |
Inquiry |
| MNAB-038 |
Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (Miniantibody) |
Human |
scFv-based Bispecific Fragments |
CD16 |
HER2 |
Inquiry |
| BSFC-H215 |
Recombinant Human Anti-CD16 x Human Anti-HER2 Bispecific Antibody (scFv-CH3) |
Human |
scFv-based Bispecific Fragments |
CD16 |
HER2 |
Inquiry |
| BSFC-038 |
Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (scFv-CH3) |
Human |
scFv-based Bispecific Fragments |
CD16 |
HER2 |
Inquiry |
| BSCC-H215 |
Recombinant Human Anti-CD16 x Human Anti-HER2 Bispecific Antibody (scFv-CH1/CL) |
Human |
scFv-based Bispecific Fragments |
CD16 |
HER2 |
Inquiry |
| BSCC-038 |
Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (scFv-CH1/CL) |
Human |
scFv-based Bispecific Fragments |
CD16 |
HER2 |
Inquiry |
| BIBD-H215 |
Recombinant Human Anti-CD16 x Human Anti-HER2 Bispecific Antibody (Bibody) |
Human |
Bibody |
CD16 |
HER2 |
Inquiry |
| BIBD-038 |
Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (Bibody) |
Human |
Bibody |
CD16 |
HER2 |
Inquiry |
| FABFV-H215 |
Recombinant Human Anti-CD16 x Human Anti-HER2 Bispecific Antibody (Fab-Fv) |
Human |
Fab-Fv |
CD16 |
HER2 |
Inquiry |
| FABFV-038 |
Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (Fab-Fv) |
Human |
Fab-Fv |
CD16 |
HER2 |
Inquiry |
| MiniB-H215 |
Recombinant Human Anti-CD16 x Human Anti-HER2 Bispecific Antibody (Minibody) |
Human |
Minibody |
CD16 |
HER2 |
Inquiry |
| MiniB-038 |
Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (Minibody) |
Human |
Minibody |
CD16 |
HER2 |
Inquiry |
| SCTB-H114 |
Recombinant Human Anti-HER2 x Human Anti-CD16 Bispecific Antibody (Single-chain Triplebody) |
Human |
Single-chain Triplebody |
CD16 |
HER2 |
Inquiry |
| SCDB-H213 |
Recombinant Human Anti-CD16 x Anti-HER2 Bispecific Antibody (Single-chain Diabody) |
Human |
Single-chain Diabody |
CD16 |
HER2 |
Inquiry |
| FABIG-H213 |
Recombinant Human Anti-CD16 x Anti-HER2 Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD16 |
HER2 |
Inquiry |
| TRIB-H215 |
Recombinant Human Anti-CD16 x Anti-HER2 Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD16 |
HER2 |
Inquiry |
| BSIG-H213 |
Human Anti-CD16 x Anti-HER2 Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD16 |
HER2 |
Inquiry |
| CROSSAB-H213 |
Recombinant Human Anti-CD16 x Anti-HER2 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD16 |
HER2 |
Inquiry |
| IGFV-H213 |
Recombinant Human Anti-CD16 x Anti-HER2 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD16 |
HER2 |
Inquiry |
| BSDB-H213 |
Recombinant Human Anti-CD16 x Anti-HER2 Bispecific Antibody (Diabody) |
Human |
Diabody |
CD16 |
HER2 |
Inquiry |
| BSFAB-H213 |
Recombinant Human Anti-CD16 x Anti-HER2 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD16 |
HER2 |
Inquiry |
| BSFV-H213 |
Recombinant Human Anti-CD16 x Anti-HER2 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD16 |
HER2 |
Inquiry |
| SCTB-014 |
Recombinant Anti-HER2 x Anti-CD16 Bispecific Antibody (Single-chain Triplebody) |
Human |
Single-chain Triplebody |
CD16 |
HER2 |
Inquiry |
| SCDB-038 |
Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (Single-chain Diabody) |
Human |
Single-chain Diabody |
CD16 |
HER2 |
Inquiry |
| FABIG-038 |
Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD16 |
HER2 |
Inquiry |
| TRIB-038 |
Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD16 |
HER2 |
Inquiry |
| BSIG-038 |
Anti-CD16 x Anti-HER2 Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD16 |
HER2 |
Inquiry |
| CROSSAB-038 |
Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD16 |
HER2 |
Inquiry |
| IGFV-038 |
Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD16 |
HER2 |
Inquiry |
| BSDB-038 |
Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (Diabody) |
Human |
Diabody |
CD16 |
HER2 |
Inquiry |
| BSFAB-038 |
Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD16 |
HER2 |
Inquiry |
| BSFV-038 |
Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD16 |
HER2 |
Inquiry |
| FABIG-035 |
Recombinant Anti-CD16 x Anti-CD32B Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD16 |
CD32B |
Inquiry |
| FABIG-034 |
Recombinant Anti-CD16 x Anti-CD30 Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD16 |
CD30 |
Inquiry |
| FABIG-025 |
Recombinant Anti-CA125 x Anti-HER2 Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CA125 |
HER2 |
Inquiry |
| TRIB-193 |
Recombinant Anti-CD16 x Anti-CD33 x Anti-CD19 Trispecific Antibody (Triple Body) |
Human |
Triple Body |
CD16 |
CD33 |
Inquiry |
| TRIB-192 |
Recombinant Anti-CD16 x Anti-CD33 x Anti-CD123 Trispecific Antibody (Triple Body) |
Human |
Triple Body |
CD16 |
CD33 |
Inquiry |
| TRIB-168 |
Recombinant Anti-HER2 x Anti-VEGF Bispecific Antibody (Triple Body) |
Human |
Triple Body |
HER2 |
VEGF |
Inquiry |
| TRIB-167 |
Recombinant Anti-HER2 x Anti-HER3 Bispecific Antibody (Triple Body) |
Human |
Triple Body |
HER2 |
HER3 |
Inquiry |
| TRIB-166 |
Recombinant Anti-HER2 x Anti-MET Bispecific Antibody (Triple Body) |
Human |
Triple Body |
HER2 |
MET |
Inquiry |
| TRIB-155 |
Recombinant Anti-EGFR x Anti-HER2 Bispecific Antibody (Triple Body) |
Human |
Triple Body |
EGFR |
HER2 |
Inquiry |
| TRIB-128 |
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD64 |
HER2 |
Inquiry |
| TRIB-114 |
Recombinant Anti-CD33 x Anti-CD16 Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD33 |
CD16 |
Inquiry |
| TRIB-111 |
Recombinant Anti-CD317 x Anti-CD16 Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD317 |
CD16 |
Inquiry |
| TRIB-090 |
Recombinant Anti-CD3 x Anti-HER2 Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD3 |
HER2 |
Inquiry |
| TRIB-037 |
Recombinant Anti-CD16 x Anti-GD2 Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD16 |
GD2 |
Inquiry |
| TRIB-036 |
Recombinant Anti-CD16 x Anti-EGFR Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD16 |
EGFR |
Inquiry |
| TRIB-035 |
Recombinant Anti-CD16 x Anti-CD32B Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD16 |
CD32B |
Inquiry |
| TRIB-034 |
Recombinant Anti-CD16 x Anti-CD30 Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD16 |
CD30 |
Inquiry |
| TRIB-025 |
Recombinant Anti-CA125 x Anti-HER2 Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CA125 |
HER2 |
Inquiry |
| BSIG-168 |
Anti-HER2 x Anti-VEGF Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
HER2 |
VEGF |
Inquiry |
| BSIG-167 |
Anti-HER2 x Anti-HER3 Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
HER2 |
HER3 |
Inquiry |
| BSIG-166 |
Anti-HER2 x Anti-MET Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
HER2 |
MET |
Inquiry |
| BSIG-155 |
Anti-EGFR x Anti-HER2 Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
EGFR |
HER2 |
Inquiry |
| BSIG-128 |
Anti-CD64 x Anti-HER2 Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD64 |
HER2 |
Inquiry |
| BSIG-114 |
Anti-CD33 x Anti-CD16 Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD33 |
CD16 |
Inquiry |
| BSIG-111 |
Anti-CD317 x Anti-CD16 Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD317 |
CD16 |
Inquiry |
| BSIG-090 |
Anti-CD3 x Anti-HER2 Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD3 |
HER2 |
Inquiry |
| BSIG-037 |
Anti-CD16 x Anti-GD2 Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD16 |
GD2 |
Inquiry |
| BSIG-036 |
Anti-CD16 x Anti-EGFR Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD16 |
EGFR |
Inquiry |
| BSIG-035 |
Anti-CD16 x Anti-CD32B Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD16 |
CD32B |
Inquiry |
| BSIG-034 |
Anti-CD16 x Anti-CD30 Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD16 |
CD30 |
Inquiry |
| BSIG-025 |
Anti-CA125 x Anti-HER2 Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CA125 |
HER2 |
Inquiry |
| CROSSAB-167 |
Recombinant Anti-HER2 x Anti-HER3 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
HER2 |
HER3 |
Inquiry |
| CROSSAB-166 |
Recombinant Anti-HER2 x Anti-MET Bispecific Antibody (CrossMab) |
Human |
CrossMab |
HER2 |
MET |
Inquiry |
| CROSSAB-155 |
Recombinant Anti-EGFR x Anti-HER2 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
EGFR |
HER2 |
Inquiry |
| CROSSAB-128 |
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD64 |
HER2 |
Inquiry |
| CROSSAB-114 |
Recombinant Anti-CD33 x Anti-CD16 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD33 |
CD16 |
Inquiry |
| CROSSAB-111 |
Recombinant Anti-CD317 x Anti-CD16 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD317 |
CD16 |
Inquiry |
| CROSSAB-090 |
Recombinant Anti-CD3 x Anti-HER2 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD3 |
HER2 |
Inquiry |
| CROSSAB-037 |
Recombinant Anti-CD16 x Anti-GD2 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD16 |
GD2 |
Inquiry |
| CROSSAB-036 |
Recombinant Anti-CD16 x Anti-EGFR Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD16 |
EGFR |
Inquiry |
| CROSSAB-035 |
Recombinant Anti-CD16 x Anti-CD32B Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD16 |
CD32B |
Inquiry |
| CROSSAB-034 |
Recombinant Anti-CD16 x Anti-CD30 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD16 |
CD30 |
Inquiry |
| CROSSAB-025 |
Recombinant Anti-CA125 x Anti-HER2 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CA125 |
HER2 |
Inquiry |
| IGFV-168 |
Recombinant Anti-HER2 x Anti-VEGF Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
HER2 |
VEGF |
Inquiry |
| IGFV-167 |
Recombinant Anti-HER2 x Anti-HER3 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
HER2 |
HER3 |
Inquiry |
| IGFV-166 |
Recombinant Anti-HER2 x Anti-MET Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
HER2 |
MET |
Inquiry |
| IGFV-155 |
Recombinant Anti-EGFR x Anti-HER2 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
EGFR |
HER2 |
Inquiry |
| IGFV-128 |
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD64 |
HER2 |
Inquiry |
| IGFV-114 |
Recombinant Anti-CD33 x Anti-CD16 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD33 |
CD16 |
Inquiry |
| IGFV-111 |
Recombinant Anti-CD317 x Anti-CD16 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD317 |
CD16 |
Inquiry |
| IGFV-090 |
Recombinant Anti-CD3 x Anti-HER2 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD3 |
HER2 |
Inquiry |
| IGFV-037 |
Recombinant Anti-CD16 x Anti-GD2 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD16 |
GD2 |
Inquiry |
| IGFV-036 |
Recombinant Anti-CD16 x Anti-EGFR Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD16 |
EGFR |
Inquiry |
| IGFV-035 |
Recombinant Anti-CD16 x Anti-CD32B Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD16 |
CD32B |
Inquiry |
| IGFV-034 |
Recombinant Anti-CD16 x Anti-CD30 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD16 |
CD30 |
Inquiry |
| BSDB-168 |
Recombinant Anti-HER2 x Anti-VEGF Bispecific Antibody (Diabody) |
Human |
Diabody |
HER2 |
VEGF |
Inquiry |
| BSDB-167 |
Recombinant Anti-HER2 x Anti-HER3 Bispecific Antibody (Diabody) |
Human |
Diabody |
HER2 |
HER3 |
Inquiry |
| BSDB-166 |
Recombinant Anti-HER2 x Anti-MET Bispecific Antibody (Diabody) |
Human |
Diabody |
HER2 |
MET |
Inquiry |
| BSDB-155 |
Recombinant Anti-EGFR x Anti-HER2 Bispecific Antibody (Diabody) |
Human |
Diabody |
EGFR |
HER2 |
Inquiry |
| BSDB-128 |
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (Diabody) |
Human |
Diabody |
CD64 |
HER2 |
Inquiry |
| BSDB-114 |
Recombinant Anti-CD33 x Anti-CD16 Bispecific Antibody (Diabody) |
Human |
Diabody |
CD33 |
CD16 |
Inquiry |
| BSDB-111 |
Recombinant Anti-CD317 x Anti-CD16 Bispecific Antibody (Diabody) |
Human |
Diabody |
CD317 |
CD16 |
Inquiry |
| BSDB-090 |
Recombinant Anti-CD3 x Anti-HER2 Bispecific Antibody (Diabody) |
Human |
Diabody |
CD3 |
HER2 |
Inquiry |
| BSDB-037 |
Recombinant Anti-CD16 x Anti-GD2 Bispecific Antibody (Diabody) |
Human |
Diabody |
CD16 |
GD2 |
Inquiry |
| BSDB-036 |
Recombinant Anti-CD16 x Anti-EGFR Bispecific Antibody (Diabody) |
Human |
Diabody |
CD16 |
EGFR |
Inquiry |
| BSDB-035 |
Recombinant Anti-CD16 x Anti-CD32B Bispecific Antibody (Diabody) |
Human |
Diabody |
CD16 |
CD32B |
Inquiry |
| BSDB-034 |
Recombinant Anti-CD16 x Anti-CD30 Bispecific Antibody (Diabody) |
Human |
Diabody |
CD16 |
CD30 |
Inquiry |
| BSDB-025 |
Recombinant Anti-CA125 x Anti-HER2 Bispecific Antibody (Diabody) |
Human |
Diabody |
CA125 |
HER2 |
Inquiry |
| BSFAB-168 |
Recombinant Anti-HER2 x Anti-VEGF Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
HER2 |
VEGF |
Inquiry |
| BSFAB-167 |
Recombinant Anti-HER2 x Anti-HER3 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
HER2 |
HER3 |
Inquiry |
| BSFAB-166 |
Recombinant Anti-HER2 x Anti-MET Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
HER2 |
MET |
Inquiry |
| BSFAB-155 |
Recombinant Anti-EGFR x Anti-HER2 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
EGFR |
HER2 |
Inquiry |
| BSFAB-128 |
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD64 |
HER2 |
Inquiry |
| BSFAB-114 |
Recombinant Anti-CD33 x Anti-CD16 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD33 |
CD16 |
Inquiry |
| BSFAB-111 |
Recombinant Anti-CD317 x Anti-CD16 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD317 |
CD16 |
Inquiry |
| BSFAB-090 |
Recombinant Anti-CD3 x Anti-HER2 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD3 |
HER2 |
Inquiry |
| BSFAB-037 |
Recombinant Anti-CD16 x Anti-GD2 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD16 |
GD2 |
Inquiry |
| BSFAB-036 |
Recombinant Anti-CD16 x Anti-EGFR Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD16 |
EGFR |
Inquiry |
| BSFAB-035 |
Recombinant Anti-CD16 x Anti-CD32B Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD16 |
CD32B |
Inquiry |
| BSFAB-034 |
Recombinant Anti-CD16 x Anti-CD30 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD16 |
CD30 |
Inquiry |
| BSFV-168 |
Recombinant Anti-HER2 x Anti-VEGF Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
HER2 |
VEGF |
Inquiry |
| BSFV-167 |
Recombinant Anti-HER2 x Anti-HER3 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
HER2 |
HER3 |
Inquiry |
| BSFV-166 |
Recombinant Anti-HER2 x Anti-MET Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
HER2 |
MET |
Inquiry |
| BSFV-155 |
Recombinant Anti-EGFR x Anti-HER2 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
EGFR |
HER2 |
Inquiry |
| BSFV-128 |
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD64 |
HER2 |
Inquiry |
| BSFV-114 |
Recombinant Anti-CD33 x Anti-CD16 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD33 |
CD16 |
Inquiry |
| BSFV-111 |
Recombinant Anti-CD317 x Anti-CD16 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD317 |
CD16 |
Inquiry |
| BSFV-090 |
Recombinant Anti-CD3 x Anti-HER2 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD3 |
HER2 |
Inquiry |
| BSFV-037 |
Recombinant Anti-CD16 x Anti-GD2 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD16 |
GD2 |
Inquiry |
| BSFV-036 |
Recombinant Anti-CD16 x Anti-EGFR Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD16 |
EGFR |
Inquiry |
| BSFV-035 |
Recombinant Anti-CD16 x Anti-CD32B Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD16 |
CD32B |
Inquiry |
| BSFV-034 |
Recombinant Anti-CD16 x Anti-CD30 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD16 |
CD30 |
Inquiry |
| BSFV-025 |
Recombinant Anti-CA125 x Anti-HER2 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CA125 |
HER2 |
Inquiry |
Fig.1 CD16A and anti-HER2 antibody pairs: orchestrating NK Cell recognition in HER2+ breast cancer cell lines.1
